Showing results (901-910 of 2,735) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|April 29, 2017
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemiaJessica Cusato, Lucio Boglione, Amedeo De Nicolò, et al.Pharmacogenomics|May 24, 2018
RICTOR gene amplification is correlated with metastasis and therapeutic resistance in triple-negative breast cancerSaid El Shamieh, Fatima Saleh, Salim Moussa, et al.Pharmacogenomics|May 24, 2018
Multi-ethnic SULT1A1 copy number profiling with multiplex ligation-dependent probe amplificationRaymon Vijzelaar, Mariana R Botton, Lisette Stolk, et al.Pharmacogenomics|September 21, 2016
Patient experiences with pharmacogenetic testing in a primary care settingSusanne B Haga, Rachel Mills, Jivan Moaddeb, et al.Pharmacogenomics|September 21, 2016
Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatmentRoelof Aj Smit, Iris Postmus, Stella Trompet, et al.Pharmacogenomics|March 19, 2010
Conference Scene: Lessons learned from the 5th Statistical Analysis Workshop of the Pharmacogenetics Research NetworkElizabeth J Atkinson, Shannon K McDonnell, John S Witte, et al.Pharmacogenomics|March 19, 2010
Haplotypes of the adrenergic system predict the blood pressure response to beta-blockers in women with essential hypertensionFabiana Filigheddu, Giuseppe Argiolas, Simona Degortes, et al.Pharmacogenomics|March 19, 2010
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han ChineseShuen-Iu Hung, Wen-Hung Chung, Zhi-Sheng Liu, et al.Pharmacogenomics|August 23, 2016
Association between DCK 35708 T>C variation and clinical outcomes of acute myeloid leukemia in South Chinese patientsDao-Yu Zhang, Xiao-Qing Yuan, Han Yan, et al.Pharmacogenomics|July 8, 2017
Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirementAlison Lh Quinn, Ina Liko, James C LeePageof 274